California State Teachers Retirement System (CalSTRS)’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
Other funds holding SPRO
ACM
BI
AVAI
AVLSA
AI
RSCM
California State Teachers Retirement System (CalSTRS)'s SPRO Position: Q2 2022 in Review
California State Teachers Retirement System (CalSTRS) sold out of Spero Therapeutics (SPRO) in Q2 2022, closing a stake of 10,256 shares — an estimated $89K sold.
California State Teachers Retirement System (CalSTRS) first reported a position in SPRO in Q4 2017 and held it in 18 quarters. The position peaked at $600K in Q4 2020. 79 funds tracked by Wall St. Rank hold SPRO as of Q2 2022.
- California State Teachers Retirement System (CalSTRS) reported no remaining Spero Therapeutics position as of Q2 2022 after selling out during the quarter.
- California State Teachers Retirement System (CalSTRS) sold 10,256 Spero Therapeutics shares in Q2 2022, an estimated $89K.
- California State Teachers Retirement System (CalSTRS) first reported a position in Spero Therapeutics in Q4 2017 and held it in 18 quarters.
- California State Teachers Retirement System (CalSTRS)'s Spero Therapeutics position peaked at $600K in Q4 2020.
- 79 funds tracked by Wall St. Rank held Spero Therapeutics as of Q2 2022.
Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2022, filed 15 Aug 2022.